Kelly R Knight

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Sexual risk taking among HIV-positive injection drug users: contexts, characteristics, and implications for prevention
    Kelly R Knight
    Center for AIDS Prevention Studies, University of California, San Francisco 94105, USA
    AIDS Educ Prev 17:76-88. 2005
  2. ncbi Sexual transmission risk behavior reported among behaviorally bisexual HIV-positive injection drug-using men
    Kelly R Knight
    Center for AIDS Prevention Studies, Department of Medicine, University of California at San Francisco, San Francisco, CA 94110 1372, USA
    J Acquir Immune Defic Syndr 46:S80-7. 2007
  3. ncbi Agents of change: peer mentorship as HIV prevention among HIV-positive injection drug users
    Sonja Mackenzie
    Health Equity Institute, San Francisco State University, San Francisco, California 94132, USA
    Subst Use Misuse 47:522-34. 2012
  4. ncbi Intimate partner violence perpetration against main female partners among HIV-positive male injection drug users
    Victoria Frye
    Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York, NY 10029, USA
    J Acquir Immune Defic Syndr 46:S101-9. 2007
  5. ncbi Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users
    David W Purcell
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 46:S35-47. 2007
  6. ncbi Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users
    Julia H Arnsten
    Division of General Internal Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10467, USA
    J Acquir Immune Defic Syndr 46:S64-71. 2007

Detail Information

Publications6

  1. ncbi Sexual risk taking among HIV-positive injection drug users: contexts, characteristics, and implications for prevention
    Kelly R Knight
    Center for AIDS Prevention Studies, University of California, San Francisco 94105, USA
    AIDS Educ Prev 17:76-88. 2005
    ..Our data emphasize a need to address the specific transmission risk contexts occurring among HIV-positive IDUs and to prioritize social and interpersonal factors when promoting safer sexual norms among HIV-positive IDUs...
  2. ncbi Sexual transmission risk behavior reported among behaviorally bisexual HIV-positive injection drug-using men
    Kelly R Knight
    Center for AIDS Prevention Studies, Department of Medicine, University of California at San Francisco, San Francisco, CA 94110 1372, USA
    J Acquir Immune Defic Syndr 46:S80-7. 2007
    ..Few research studies have examined the HIV transmission risk behaviors of HIV-positive injection drug users (IDUs) who are men who have sex with men and women (MSMW)...
  3. ncbi Agents of change: peer mentorship as HIV prevention among HIV-positive injection drug users
    Sonja Mackenzie
    Health Equity Institute, San Francisco State University, San Francisco, California 94132, USA
    Subst Use Misuse 47:522-34. 2012
    ..This study was funded by the Centers for Disease Control and Prevention and Health Resources and Services Administration (HRSA)...
  4. ncbi Intimate partner violence perpetration against main female partners among HIV-positive male injection drug users
    Victoria Frye
    Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York, NY 10029, USA
    J Acquir Immune Defic Syndr 46:S101-9. 2007
    ..IPV assessment and treatment among HIV-positive men in HIV care is recommended as a way to prevent IPV perpetration and victimization and to reduce potential HIV transmission...
  5. ncbi Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users
    David W Purcell
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 46:S35-47. 2007
    ..We sought to evaluate the efficacy of an intervention to reduce sexual and injection transmission risk behaviors and to increase utilization of medical care and adherence to HIV medications among this population...
  6. ncbi Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users
    Julia H Arnsten
    Division of General Internal Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10467, USA
    J Acquir Immune Defic Syndr 46:S64-71. 2007
    ..Active drug use is often associated with poor adherence, but few studies have determined psychosocial correlates of adherence in injection drug users (IDUs)...